Current progress in understanding of cholestasis and autoimmune liver diseases——Meeting review about 1^(st) symposium on cholestasis and autoimmune liver disease
2Trauner M, Boyer JL. Bile salt transporters : molecular characterization, function, and regulation [J]. Physiol Rev, 2003, 83 (2) : 633-671.
3Lee JM, Trauner M, Soroka C J, et al. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat [J]. Gastroenterology, 2000, 118 (1):163-172.
4Zollner G, Fickert P, Zenz R, et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases [J]. Hepatology, 2001, 33 (3): 633-646.
5Zollner G, Fickert P, Silbert D, et al. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis[J]. J Hepatol, 2003, 38 (6) : 717-727.
6Oswald M, Kullak-Ublick GA, Paumgartner G, et al. Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis [J]. Liver, 2001, 21 (4) : 247-253.
7Marinelli RA, Lehmann GL, Sofia LR, et al. Hepatocyte aquaporins in bile formation and cholestasis [J]. Front Biosci, 2011, 17 : 2642-2652.
8Sinal C J, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis[J]. Cell, 2000, 102 (6): 731-744.
9Kok T, Hulzebos CV, Wolters H, et al. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein[J]. J Biol Chem, 2003, 278 (43): 41930-41937.
10Zollner G, Fickert P, Fuchsbichler A, et al. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine [J]. J Hepatol, 2003, 39 (4): 480-488.
